Viewing StudyNCT01215487



Ignite Creation Date: 2024-05-05 @ 10:54 PM
Last Modification Date: 2024-10-26 @ 10:26 AM
Study NCT ID: NCT01215487
Status: COMPLETED
Last Update Posted: 2021-04-30
First Post: 2010-10-04

Brief Title: A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib
Sponsor: University of British Columbia
Organization: University of British Columbia

Organization Data

Organization: University of British Columbia
Class: OTHER
Study ID: H09-03255
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of British Columbia
Lead Sponsor Class: OTHER
Responsible Party: Donna Forrest
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: University of British Columbia
Old Name: None
Old Organization: None

Collaborators

Name Class
Bristol-Myers Squibb INDUSTRY